The Fast Money traders take a look at today's biggest market movers.» Read More
President Barack Obama warned that failure to act on an economic recovery package could plunge the nation into a long-lasting recession that might prove irreversible, a fresh call to a recalcitrant Congress to move quickly.
Royal Bank of Scotland, now 68 percent owned by the UK government, still plans on paying out bonuses that could reach tens of million to hundreds of millions of pounds, London newspaper The Times reported Wednesday.
President Obama launched a campaign to rein in corporate compensation with rules limiting executive pay. Below are the new rules and restrictions on executive compensation issued by the Treasury Department.
Shares of Swiss drugmaker Roche are trading significantly lower overseas and in over-the-counter activity here in the States after the company reported earnings.
President Obama kicks off a campaign to rein in corporate compensation with rules limiting executive pay to $500,000 a year for companies getting taxpayer bailout funds in the future.
Why stop with executives? Let’s slap the pay cap on any business that does work for the government, and firms that want a piece of the stimulus package, and university labs that get federal grants. No doubt the compensation critics would love to take a whack at the yawning gap between salaries in the C-suite and the factory floor.
Disney CEO Bob Iger blames lower theme-park attendance (and subsequent price-cutting), reduced broadcast advertising revenue and disappointing film revenues for his company's disappointing results.
Plus, a call on Fortune Brands: raise your glasses in toast, or is it a tear-down?
If Wall Street heads don't roll for causing this market crisis, the Mad Money host says, we could see a dozen more Bernie Madoffs.
Hank Greenberg, chairman and CEO at C.V. Starr and Co. and former CEO of AIG, told CNBC's Asia Squawk Box that it's clear AIG is more than a troubled company. Greenberg said the once dominant insurance company, needs to be rebuilt .
Ford reported January sales dropped 42 percent, which is far worse than the estimate on Wall Street of a decline of 31 percent. On the surface, this would appear to support concerns that the auto market has not stabilized. I'm not sure that is a fair conclusion. Here's why.
Strange as it sounds, January auto sales could wind up being worse than the dismal numbers we saw in December. While that may lead some people to think the auto market and consumer are getting weaker, the reality could be far different.
Before Gardasil came to market two to three years ago, some analysts were saying it would become the biggest-selling vaccine in history. But hope and reality have turned out to be two different things.
JPMorgan Chase Chairman and Chief Executive Jamie Dimon thinks outrage over bonuses being paid to executives of firms involved in the financial crisis and now receiving federal assistance is not entirely justified. In his keynote speech to the Future Of New York conference sponsored by Crain's New York, Dimon took issue with President Obama's characterization of bonuses and the way they have been paid out.
Pfizer CEO Jeffrey Kindler defends his company's plan to acquire rival Wyeth for $68 billion in the biggest pharmaceutical merger in eight years, despite a plunge of more than 16 percent in Pfizer's stock price last week.
For GM and Chrysler, this is when the good stuff will start happening. After a month of seeing relatively little from GM and Chrysler about how they plan to restructure their operations, we could be on the verge of a couple busy months.
So, what do you do at the end of a week where your company's stock was the worst performer in the Dow and you've got some bad news that could make the shares go down even more? You employ one of the oldest PR tricks in the book.
What pay extra to keep managers when there are no other jobs in the market? Plus, Cramer explains how we save the housing market.
Not all the president’s men are worth owning, Cramer says. Check out his company-by-company review of Barack Obama’s economic support team.
Genentech shares dropped three percent today or $2.85 to $81.24 after Roche showed some chutzpah and lowered its bid for DNA.